Dr. Ross has pioneered the field of regenerative exosomes, isolating, quantifying and characterizing these cellular signals in his 25,000 square foot cGMP laboratory with the latest technology.
The World's Leader in Stem Cell Surgery and Science
Dr. Ross has pioneered the field of regenerative exosomes, isolating, quantifying and characterizing these cellular signals in his 25,000 square foot cGMP laboratory with the latest technology.
In this episode of RegenaCast, host Sean welcomes Dr. Duncan Ross, the founder of Chimera Exosomes and a pioneer in the field of exosome research. Dr. Ross dives into his journey from immunology and microbiology to leading the exosome field, initially driven by his personal connection to leukemia research. He shares how his discovery of exosomes began when he noticed that using the supernatant from young, healthy cells helped older, less healthy cells grow—a finding that led to his groundbreaking work with exosomes.
Exosomes, as Dr. Ross explains, are packets of information secreted by cells that play a key role in cellular communication and regeneration. He outlines the difference between his exosome products, such as ExoGlo and Luxier, which offer varying levels of benefits for growth, anti-inflammatory effects, and healing. Dr. Ross also discusses the significant research that Chimera Exosomes has invested in, including a breakthrough study demonstrating that exosomes can cross the blood-brain barrier when paired with focused ultrasound technology.
The conversation highlights the applications of exosomes in aesthetics, wound healing, and their use alongside stem cells in regenerative medicine. Dr. Ross emphasizes the importance of proper characterization, quantification, and clinical validation of exosomes, distinguishing his work from others in the field.
If you’re intrigued by regenerative medicine and want to hear more, don’t forget to attend the Cell Surgical Conference Las Vegas this June! It’s a great opportunity for professionals and those interested in cutting-edge stem cell therapies and more.